HYBRID EVENT: You can participate in person at Orlando, USA or Virtually from your home or work.

6th Edition of International Conference on Neurology and Brain Disorders

October 24 -26, 2022

October 24 -26, 2022 | Orlando, Florida, USA

INBC 2022

Speaker at Neurology and Brain Disorders 2022 - W S El Masri
Keynote Presentation (In-Person)
W S El Masri, Keele University, United Kingdom

Spontaneous Neurological Recovery is very common in patients with incomplete traumatic spinal cord injuries. This is provided no further mechanical and non-mechanical damage is inflicted onto the injured cord. Currently there is great deal of emphasis on the threats of the Biomec [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Calixto Machado
Keynote Presentation (In-Person)
Calixto Machado, Institute of Neurology and Neurosurgery, Cuba

I was a main expert in the case of Jahi McMath, who was diagnosed with brain death (BD). Nonetheless, ancillary tests performed nine months after the initial brain insult showed conservation of intracranial structures, EEG activity, and autonomic reactivity to the “Mother T [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

The human central nervous system (CNS) fundamentally does something elegant and simple and is programmed to abide by some simple sets of rules and initial conditions. Fundamentally, the CNS takes in and perceives information coming in from the outside world and responds to it. Ho [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Marianna Mekhaeil
Oral Presentation (In-Person)
Marianna Mekhaeil, Trinity college Dublin, Ireland

Metachromatic leukodystrophy (MLD) is a rare genetic disorder that affects the central nervous system white matter. MLD is caused by recessive mutations in ARSA encoding arylsulfatase A. Low activity of arylsulfatase A results in the accumulation of sulfatides in the central and [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Fulya Turker
Oral Presentation (In-Person)
Fulya Turker, Johns Hopkins University School of Medicine, United States

Proteasome complexes play a critical role in human brain health and disease. Despite enormous effort, a deep understanding of proteasome composition, activity, and abundance in the human brain remains poorly understood. Here, we describe a series of tools that can measure the cat [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Jose Iranildo Sales
Oral Presentation (In-Person)
Jose Iranildo Sales, Mauricio de Nassau University of Medicine, Brazil

Background: Recent studies have raised the possibility and clinical feasibility of using treatments using oxygen therapies in hyperbaric chambers (HBOT) for the analysis of functional and cognitive improvements in patients after ischemic and hemorrhagic strokes. The effects in ce [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Manas Ranjan Sahu
Oral Presentation (In-Person)
Manas Ranjan Sahu, Jawaharlal Nehru University, India

Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disorder associated with aging. Persons with Alzheimer's face some serious problems associated with memory, thinking, motor movements, language, and behavior due to neurodegen [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Simon Barton
Oral Presentation (In-Person)
Simon Barton, Talking Magnets LLC, United States

Those of us fortunate enough to have survived a (massive) stroke event often embark on the post-stroke “journey of recovery” without the correct tools to properly manage it. We will hear and retain certain messaging repeatedly, for example, “I cannot tell you h [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Maria Gerliane Cavalcante
Oral Presentation (In-Person)
Maria Gerliane Cavalcante, Mauricio de Nassau University of Medicine, Brazil

Background: Recent studies have raised the possibility and clinical feasibility of using treatments using oxygen therapies in hyperbaric chambers (HBOT) for the analysis of functional and cognitive improvements in patients after ischemic and hemorrhagic strokes. The effects in ce [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Michelle Herman
Oral Presentation (In-Person)
Michelle Herman, Michelle Herman Speaks, United States

At the age of 32, and 6 months postpartum from having her first child, Michelle walked into the ER with impaired motor skills on the left side of her body, a horrible headache and slurred speech. She was diagnosed with a migraine and discharged. Two days later she had a massive I [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Bhanu Sharma
Oral Presentation (In-Person)
Bhanu Sharma, Delhi University, India

Neurons and glial cells work in conjunction with each other during information processing in brain. Stimulation of neurons can cause calcium oscillations in astrocytes which in-turn can affect neuronal calcium dynamics. The “glissandi” effect is associated with a decr [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Arman John Fijany
Oral Presentation (In-Person)
Arman John Fijany, TCU School of Medicine, United States

Pain is an uncomfortable sensation perceived by the nervous system that can have a variety of different causes. Pain can be seen as a complication of disease, emotional states and even as a standalone pathology. The neuroscience of pain is poorly understood. Multiple levels of co [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Dell G Mars
Oral Presentation (In-Person)
Dell G Mars, Southeastern Louisiana University School of Nursing, United States

Purpose: The purpose of this qualitative study was to describe the lived experience of African American informal caregivers of family members of Alzheimer’s Disease and Related Dementias (ADRD) in a home environment. Design and Method: This phenomenological descriptive [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Lakshmi Sundeep
Oral Presentation (In-Person)
Lakshmi Sundeep, Hindustan Institute of Technology and Science, India

Acute Ischemic Stroke (AIS) is a life-threatening cerebrovascular illness. The cause of AIS is unknown, and treatment options are limited. The study is to find out which genes are expressed in AISs and use that information to guide future research and treatment. The raw datasets [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Andreas Till
Oral Presentation (In-Person)
Andreas Till, University of Bonn, Germany

Given the complex etiopathology of neurodegenerative diseases and the limited access to vital human brain cells as suitable research platform, there is an increasing demand of innovative human-specific model systems that help elucidating the causative mechanisms of these disorder [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Rizwan Khan
Oral Presentation (In-Person)
Rizwan Khan, Western Sydney University, Australia

Alzheimer’s disease (AD) is on a rapid rise in the aged population with typical hallmarks of extracellular Aβ deposits and intracellular neurofibrillary tangles (NFT) composed of hyperphosphorylated tau proteins. Positron emission tomography imaging and screening for A [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sachin Kumar
Oral Presentation (In-Person)
Sachin Kumar, Western Sydney University, Australia

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, clinically characterised by progressive impairment of memory, cognitive ability, and behavioural changes. As per World Health Organisation statistics 55 million people are currently living with dementia. [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Brandon William Moritz
Poster Presentation (In-Person)
Brandon William Moritz, University of Oklahoma College of Medicine, United States

A 23-year-old Caucasian male with a past medical history of anxiety, pilonidal cyst removal from the lower back in 2 years ago, and EBV infection 1 month ago presents to an on-campus eye institute after 1 week of binocular diplopia, headache, intermittent muscle weakness, neck so [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Solomon Nittala DO MS
Poster Presentation (In-Person)
Solomon Nittala DO MS, Larkin Community Hospital Palm Springs Campus, United States

Originally described in 1964, progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy with a prevalence of approximately 45% among other parkinsonian-plus syndromes. PSP can be categorized into various phenotypes among which 6% belong to the PSP-frontal predominan [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Maria R Cochran Perez
Poster Presentation (In-Person)
Maria R Cochran Perez, Universidad Central del Caribe Internal Medicine Residency Program, Puerto Rico

Introduction Neurotoxoplasmosis is an infection caused by Toxoplasma gondii, an intracellular protozoan that is often associated with immunocompromised patients, being rare in immunocompetent patients and often undetected. Toxoplasmosis is an obligate intracellular, food-borne [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Ana Martes Bermúdez
Poster Presentation (In-Person)
Ana Martes Bermúdez, UCC Internal Medicine Residency Program, Puerto Rico

Introduction: There have been increasing reports associating coronavirus disease 2019 (COVID-19) with thromboembolic phenomenon including cerebral venous thrombosis (CVT), which is a rare neurovascular emergency often found in critically ill patients, yet its true incidence [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Aygun BadaLova
Poster Presentation (In-Person)
Aygun BadaLova, University College London, United Kingdom

One of the most common and prevalent neurodegenerative disorders are Alzheimer's and Dementia which are considered significant causes of mortality and morbidity in today’s society particularly among the elderly population.(Erkkinen, Kim et al. 2018)The etiologic and pat [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Neil Gerts
Poster Presentation (In-Person)
Neil Gerts, Los Robles Regional Medical Center, United States

The World Health Organization declared COVID-19 a pandemic in February 2020, and it has affected the life of each and everyone. COVID-19 is designated as severe respiratory syndrome coronavirus 2 (SARS-CoV-2). It causes an acute inflammatory process in the body, which is hypothes [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Firaoly Workneh
Poster Presentation (In-Person)
Firaoly Workneh, St Paul hospital millennium medical college, Ethiopia

Background Increased intracranial pressure is a common and possibly fatal complication of neurologic and systemic diseases. Diagnosis is made mainly based on clinical and neuroimaging findings.  There are medical and surgical treatment options. Early diagnosis and prompt [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Flavia I Spiroiu
Poster Presentation (In-Person)
Flavia I Spiroiu, McMaster University, Canada

BACKGROUND: Despite the potential importance of intolerance of uncertainty (IU) as a transdiagnostic feature that may contribute specifically to social anxiety, empirical data on the construct has been relatively scant and focused largely on Generalized Anxiety Disorder (GAD) and [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Maral Kasiri
Poster Presentation (In-Person)
Maral Kasiri, University of California, United States

Understanding the relationship between neural activity and voluntary movement provides new insights into understanding the mechanism underlying neural control of movement in both healthy people and those with movement disorders. To investigate the relationship between deep brain [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Rebecca Lees
Poster Presentation (In-Person)
Rebecca Lees, Guthrie Robert Packer Hospital, United States

Stroke is the number one preventable cause of disability and a leading cause of death in both men and women; rapid assessment and treatment is critical to improve outcomes for patients. Guthrie Robert Packer Hospital received The Joint Commission Primary Stroke Center certificati [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Vildan Tuncbilek
Poster Presentation (In-Person)
Vildan Tuncbilek, Tekirdağ Namık Kemal University, Turkey

Autoimmunity reflects an altered immune status, therefore the presence of more than one disorder is not uncommon. The coexistence of three or more autoimmune diseases in a patient constitutes multiple autoimmune syndrome (MAS). This is an interesting case of a middle-aged female [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Judith Stefanie Scheller
Poster Presentation (In-Person)
Judith Stefanie Scheller, Institute of Physiological Chemistry, Ulm University, Germany

Inflammaging represents an accepted concept where the immune system shifts to a low-grade chronic proinflammatory state without overt infection upon aging. In the CNS, inflammaging is mainly driven by glia cells and associated with neurodegenerative processes. White matter degene [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Flavia I Spiroiu
Poster Presentation (In-Person)
Flavia I Spiroiu, McMaster University, Canada

Background. Obsessive-compulsive disorder (OCD) is a common and severe psychiatric disorder. Cognitive behavior therapy (CBT) with exposure and response prevention (ERP) is the gold standard intervention for OCD, but more than 40% of patients with this disorder remain impaired ev [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Beata Lindholm
Poster Presentation (In-Person)
Beata Lindholm, Lund University, Sweden

We have investigated how a de novo cohort of people with Parkinson’s disease (PD) differs in terms of balance and gait function as well as frequency of near falls and falls in comparison to a cohort with mild to moderate PD that has been medicated for several years. Prelimi [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Neha Singh
Oral Presentation (In-Person)
Neha Singh, Dayalbagh Educational Institute, India

Pervasive use of pesticides in all over the word that may affect human nervous system extensively. Likewise pyrethroids are the major group of pesticides that is used in household products from where human get affected and suffer with various neurological disorders such as Parkin [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sandeep
Oral Presentation (In-Person)
Sandeep, Jawaharlal Nehru University, India

Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra and presence of intra- cytoplasmic inclusion bodies known as lewy body containing α- synuclein aggregate . [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Dagnachew Yohannes Gechera
Oral Presentation (In-Person)
Dagnachew Yohannes Gechera, Hawassa University, Ethiopia

Background: In Ethiopia, the pattern of neurosurgical disorders and operations is poorly known. The aim of this study was to describe the neurosurgical disease and surgery patterns at two major hospitals in southern Ethiopia. Patients and Methods: This is a retrospective analysi [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Austin Walker
Oral Presentation (In-Person)
Austin Walker, University of Oklahoma School of Medicine, United States

Explanation of the most fundamental roles of neurotransmitters is missing from current medical science. A good description of function should be simple and should act as a framework that allows for more complexity. I propose a simple model of neurotransmitter function that exhibi [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Benjamin Pinker
Oral Presentation (In-Person)
Benjamin Pinker, Karol Marcinkowski University of Medical Science, Poland

Meningiomas are the most frequent primary tumors arising in the central nervous system. They typically follow a benign course, with an excellent prognosis for grade I lesions through surgical intervention. Although radiotherapy is a good option for recurrent, progressive, or in [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Ahmad Farooqi
Oral Presentation (In-Person)
Ahmad Farooqi, Central Michigan University, United States

Parkinson’s is a neurodegenerative progressive disease it affects human brain functionality as the disease progresses. It mostly affects movement, slows down the functionality of motor areas, and increases the difficulty in performing any task for the patients. Resting stat [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hamdiollah Hassanlouei
Oral Presentation (In-Person)
Hamdiollah Hassanlouei, Shahid Beheshti University, Iran (Islamic Republic of)

Aging is associated with reduced neuromuscular function, which may be due in part to altered corticospinal excitability. Regular physical activity (PA) may ameliorate these age-related declines, but the influence of PA on corticospinal excitability is unknown. The purpose of this [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Lloyd L Tran
Oral Presentation (In-Person)
Lloyd L Tran, Biomed Industries, Inc., United States

In the hippocampus, new neurons are generated throughout life via a process called adult hippocampal neurogenesis (AHN). In mild cognitive impairment (MCI) and mild to moderate AD (early AD), AHN is significantly reduced suggesting that AHN impairment compromises hippocampal func [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Shely Azrad-Daniel
Oral Presentation (In-Person)
Shely Azrad-Daniel, Hospital Angeles Lomas, Mexico

An acute disseminated encephalomyelitis (ADEM) is very challenging to diagnose. ADEM is rare, inflammatory and demyelinating disease that affects the central nervous system (CNS) with a typically white matter damage. ADEM often occurs following a viral or bacterial infection, or [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mohamed Kamel
Oral Presentation (In-Person)
Mohamed Kamel , Cairo University, Egypt

Traumatic brain injury (TBI) is defined as a traumatically-induced structural brain injury or physiological disruption of brain function caused by an external force. Traumatic brain injury is a neuropsychiatric disorder that breaks down the remaining barriers between neurology an [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Thomas J Webster
Oral Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Nanotechnology has revolutionized numerous industries, particularly medicine. Nanoparticles, nanotubes, drug delivery nanoparticles, and nanotextured neural probes are just several of many examples where nanomedicine is positively impacting neuroscience. This presentation will su [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Ulrich Sprick
Oral Presentation (In-Person)
Ulrich Sprick, Alexius/Josef Clinic, Neuss, Germany

Patients with severe therapy-resistant depressive disorders repeatedly pose enormous treatment challenges in psychiatry and neurology. Transcranial pulse stimulation (TPS) as a new non-invasive therapy method could represent a new alternative to standard treatment such as ECT, ma [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Smaili Rachid
Poster Presentation (In-Person)
Smaili Rachid, University hospital of Tangier- Tétouan-Al Hoceima, France

Background: Creutzfeldt Jakob disease (CJD) is a fatal and rare neurodegenerative disease, It is classified into 3 subgroups: sporadic, genetic and acquired. Sporadic CJD is the most common form, which may be manifested with misleading neuropsychiatric symptoms and resulting in [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - S. M. Umirova
Poster Presentation (In-Person)
S. M. Umirova, Tashkent Medical Academy, Uzbekistan

Currently, there is a large increase in the number of cases of coronavirus infection caused by COVID-19. A severe complication of diabetes is diabetic polyneuropathy, which is exacerbated by a new coronavirus infection. Purpose of the study began to evaluate the possibilities [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Ilhan Yu
Poster Presentation (In-Person)
Ilhan Yu, Nowon eulji university hospital, Korea, Republic of

Background Severe acute respiratory syndrome coronavirus 2 is a coronavirus that has recently appeared, rapidly spreads, and results in coronavirus disease 2019 (COVID-19). Moderna mRNA-1273 and Pfizer-BioNTech BNT162b2 vaccines are among the most widely used and effective va [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Tukhtamisheva Dildora Rustamovna
Poster Presentation (In-Person)
Tukhtamisheva Dildora Rustamovna, Akfa Medline Private Hospital, Uzbekistan

In economically developed countries of the world, cardiovascular diseases nowadays represent the general factor of mortality. From year to year, in the order of 15 million people, acute cerebrovascular accident (ONMC) is formed. In various countries of the earth, the incidence of [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Rebecca Simon
Poster Presentation (In-Person)
Rebecca Simon, Nova Southeastern University, United States

Correct identification and analysis of intracranial masses is of high clinical importance especially when it comes to treating acute illnesses and focal neurological deficits, while preventing further deterioration. We present a rare case of a giant thrombosed aneurysm in the [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Luis A Sierra
Poster Presentation (In-Person)
Luis A Sierra, Beth Israel Deaconess Medical Center, United States

Background: A diagnosis of manifest Huntington’s disease (HD) is based primarily on motor symptoms, but early cognitive decline is common in the pre-manifest HD period (preHD). Early symptom detection in HD has important implications for monitoring both disease pr [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mary Kemberly S Trinidad
Poster Presentation (In-Person)
Mary Kemberly S Trinidad, Perpetual Succour Hospital, Philippines

Background:  Hemifacial spasm (HFS), characterized by unilateral, intermittent contractions of the muscles of facial expression occurs due to vascular compression of the facial nerve at the root exit zone. Few studies demonstrated the total prevalence of HFS in range of 9.8 [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Chandra Mohan Bhaedwaj
Poster Presentation (In-Person)
Chandra Mohan Bhaedwaj, SGT Medical College, India

McLeod neuroacanthocytosis syndrome is a ultra rare genetic disorder that occurs almost exclusively in males.It affects brain and spinal cord. Affected individual develops jerky movements of arms, legs, dystonia of face ,tongue which ultimately leads to swallowing difficulty. It [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Johanna Christina Reiners
Poster Presentation (In-Person)
Johanna Christina Reiners, Ulm University, Germany

Stress is generally defined as a real or interpreted threat to the psychological or physiological integrity of an individual that results in physiological and/or behavioral responses. Threatening stimuli trigger neuronal responses in the brain that cause an immediate adaptive sys [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Min Sung Gee
Poster Presentation (In-Person)
Min Sung Gee, Kyung Hee University, Korea, Republic of

Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal cell loss and cognitive impairment are pathological symptoms of Alzheimer’s disease (AD). Regarding these symptoms, resolution of neuroinflammation and inhibition of Aβ-driven pathology m [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Gerald W. Grass
Poster Presentation (In-Person)
Gerald W. Grass, Ketamine Research Institute, United States

Objective: Ketamine is recognized as a rapidly acting antidepressant; however, discrepancies exist between the "Efficacy" reported in research studies (70-85%) versus significantly lower "Effectiveness" (18.3-45.5%) reported in community-based settings. To off [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sulaymanov Khurshid
Poster Presentation (In-Person)
Sulaymanov Khurshid, TTA, Uzbekistan

Today, 40% of vascular diseases are acute cerebrovascular accidents, of which 83.8% lead to disability. 17.4% end in death. Every year, 60,000 patients with cerebrovascular accidents are admitted to the hospital. In the multidisciplinary clinic of the Tashkent Medical Academy, [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Kamariddinova Mokhira
Poster Presentation (In-Person)
Kamariddinova Mokhira, TTA, Uzbekistan

Relevance of the topic: Currently, 1 out of 7 people in the world suffer from migraine, do not go to school, and even in the case of walking, working capacity is sharply reduced. Purpose: to rehabilitate migraine patients to a stable lifestyle by reducing pain attacks. Mate [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Reem Ahmad Abedi
Oral Presentation (Virtual)
Reem Ahmad Abedi, American University of Beirut, Lebanon

Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Penetrating brain injury (PBI), represents ~ 12% of all TBI cases. Typically, PBI is associated with many symptoms including coma. The mechanisms underlying these pathologic changes include excitotox [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hayat Abdoallah Ahmed Bashir
Oral Presentation (Virtual)
Hayat Abdoallah Ahmed Bashir, University of Khartoum, Sudan

Keywords Inhalants, Glue  , neuropsychiatric manifestation ,Silsion ,Sudan. Introduction Inhalants abuse is the behaviour of sniffing or huffing of volatile psychoactive substances to reach an euphoric feelings. Inhalants use reported to have so many neurological&nb [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Nawaj Pathan
Oral Presentation (Virtual)
Nawaj Pathan, MGM School Of Physiotherapy, Aurangabad, India

The Stroke survivor’s biggest challenges are to deal with muscle weakness which is primarily in upper limb, trunk, and lower limb. Additionally, the altered muscle tone, abnormal synergy pattern, impaired coordination and postural control delays the recovery of clients. The [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Lama Saad El-Din Mahmoud
Oral Presentation (Virtual)
Lama Saad El-Din Mahmoud, October 6 University, Egypt

Background/Aims: Parkinsonism characterized by deficits in cognitive functions that affect the motor control. The main aim was to assess the effect of motor learning feedback with augmented cues of motor learning on cognitive functions and motor performance in patients with Parki [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Harinder Jaseja
Oral Presentation (Virtual)
Harinder Jaseja, NIMS University, India

Deep brain stimulation (DBS) of anterior thalamic nucleus (ATN) has established as an effective adjunctive therapy for patients with intractable epilepsy (IE) not suitable for epilepsy brain surgery and/or vagal nerve stimulation. The judicious selection of DBS parameters (DBSPs) [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hamza Wadi
Oral Presentation (Virtual)
Hamza Wadi, Mutah University, Jordan

 Background and aims:  Sleep quality is a key aspect of the overall psychological health. Sleep quality can affect mental health in many aspects, causing major psychological disorders, such as: depression and anxiety. Objectives:  to assess the overall psy [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Anisha C D
Oral Presentation (Virtual)
Anisha C D, PSG College of Technology, India

Identified Problems: Parkinson Disorder (PD) is the most common neurodegenerative disorder after Alzheimer Disease. There is no specific test for diagnosis of PD which increases the complexity of manual physical examination with less validation. PD does not have cure but its prog [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Surendra S. Wadikar
Oral Presentation (Virtual)
Surendra S. Wadikar, Topiwala National Medical College, India, India

The stress response involves multiple organ systems like central nervous system, autonomic nervous system, endocrine system, cardiovascular system and immune system. Individual’s responses to stressors are conditioned by the genetic, environmental and developmental factors. [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Lilit Darbinyan
Oral Presentation (Virtual)
Lilit Darbinyan, Orbeli Institute of Physiology, Armenia

Parkinson's disease (PD) is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain called substantia nigra which controls movement. A hallmark feature of PD is the degeneration of the dopamine neurons in the substanti [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sumaira Kanwal
Oral Presentation (Virtual)
Sumaira Kanwal, COMSATSuniversity Islamabad Sahiwal campus, Pakistan

Epilepsy is one of the most common neurological disorders and is more common in developing countries as compared to developed one. Epilepsy has a various types of phenotype depends upon the pathways involved in the signaling process. Epilepsy is a group of neurological disorders [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Elmira Panakhova
Oral Presentation (Virtual)
Elmira Panakhova, Institute of Physiology, Academy of Sciences of Azerbaijan, Azerbaijan

In electrophysiological experiments, we previously found that a local focus of excitation caused by instillation of a 2% strychnine solution into the Basolateral Amygdala (BLA) led to an increase in the amplitude parameters of evoked potentials (EP) in the Visual Cortex and Lat [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Marina Martinez Vargas
Oral Presentation (Virtual)
Marina Martinez Vargas, Baylor College of Medicine, United States

von Willebrand factor (VWF) is a multimeric protein that mediates thromboinflammation and has been linked to traumatic brain injury (TBI), specifically in the pathogenesis of early brain injury. Activated endothelium secretes VWF multimers as long hyperadhesive strings. During TB [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Kunal Bhanot
Oral Presentation (Virtual)
Kunal Bhanot, Imperial College London, United Kingdom

The increasing prevalence of blast traumatic brain injury (bTBI) in military personnel has stimulated further research into this field. The neuroendocrine system can be severely affected in blast survivors and anterior pituitary dysfunction has been characterised in soldiers retu [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Divya Midha
Oral Presentation (Virtual)
Divya Midha, Punjabi University, India

Stroke is the second most leading cause of mortality and disability across the globe. Stroke is one of the major public health problems especially in developing countries like India that pose multiple challenges to the stroke survivors, their care-givers and to the team of heal [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sajjad Saghebdoust
Oral Presentation (Virtual)
Sajjad Saghebdoust, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Percutaneous iliosacral screw fixation in posterior pelvic ring fractures is a challenging operation and commonly performs under fluoroscopy or navigation techniques. The purpose of this study was to assess the safety and efficacy of percutaneous iliosacral screw im [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Yasemin Tuğçe Yayla
Oral Presentation (Virtual)
Yasemin Tuğçe Yayla, Memorial Sisli Hospital, Turkey

Background: Stroke is a disabling disease due to its functional impairments and complications. In this study, we aimed to examine the clinical profiles, practical outcomes, and complications during rehabilitation of patients hospitalized with stroke. Methods: In this single ce [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sajjad Saghebdoust
Oral Presentation (Virtual)
Sajjad Saghebdoust, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: The effect of systemic tranexamic acid (TXA) administration on blood loss reduction during spine surgeries has been widely published over the past decade. However, topical use of TXA during cervical spine surgery is rarely investigated. We aimed to assess the role o [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Priyanka Sethi
Oral Presentation (Virtual)
Priyanka Sethi, GD Goenka University, India

Background: Fibromyalgia (FM) is a chronic disorder with persistent manifestation of pain, mood swings, fatigue, depression and attention deficits that affects one’s activity of daily living. Objective: The present study aimed to find prevalence and diagnosis of Fibromya [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Armaan Saith
Oral Presentation (Virtual)
Armaan Saith, Temple University, United States

ADHD is the most common neurobehavioral disorder of childhood characterised by inattention, impulsivity and motor hyperactivity. The estimated number of children ever diagnosed with ADHD, according to a national 2016 parent survey is 6.1 million (9.4%). An estimated 8.7 million a [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Bhargavi R Budihal
Oral Presentation (Virtual)
Bhargavi R Budihal, BGS Global Institute of Medical Sciences, India

Background: Multidetector CT angiography (MDCTA) is widely used for the detection of large vessel occlusion in acute ischaemic stroke. This modality has not been used in the assessment of lenticulostriate (LSA) or anterior choroidal artery (AChA) occlusion that results in basal g [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - David Chang
Oral Presentation (Virtual)
David Chang, NHS Hull University Teaching Trust, United Kingdom

Background Venous thromboembolism(VTE) prophylaxis is a recognised part of stroke management in European Stroke Organisation (ESO) guidelines[1], and a component in the NICE Stroke pathway[2]. The practicalities of the prescribing and application of these modalities whether phar [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Leya Maliekal
Oral Presentation (Virtual)
Leya Maliekal, Wayne State University School of Medicine, United States

Rubral tremors, or Holmes’ tremors, are a type of movement disorder that appear post-cerebellar/thalamic injury. Optimal treatment approaches for rubral tremors are still being understood and include pharmacological options such as dopamine precursors, anticonvulsants, and [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Du Yang
Oral Presentation (Virtual)
Du Yang, Shanghai Jiao Tong University School of Medicine, China

Late-onset Alzheimer’s disease (LOAD) and early-onset Alzheimer’s disease (EOAD) are different subtypes of AD. This study aimed to build and validate radiomics models of the hippocampus for EOAD and LOAD. Thirty-six EOAD patients, 36 LOAD patients, 36 YCs, and 36 OCs [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Elias mazrooei
Oral Presentation (Virtual)
Elias mazrooei, Khavaran Higher Education Institute, Iran (Islamic Republic of)

The main purpose of this study is to provide a method for early diagnosis of Alzheimer's disease. This disease reduces memory function by destroying neurons in the nervous system and reducing connections and neural interactions. Alzheimer's disease is on the rise and ther [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Sumit Kumar
Oral Presentation (Virtual)
Sumit Kumar, ISF College of Pharmacy, India

Methylmercury (MeHg+) is a known neurotoxin that causes progressive motor neuron degeneration in the central nervous system. Axonal degeneration, oligodendrocyte degeneration, and myelin basic protein (MBP) deficits are among the neuropathological abnormalities caused by MeHg+ in [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Annapurna Ahuja
Oral Presentation (Virtual)
Annapurna Ahuja, Hazaribag College of Dental Sciences and Hospital, India

Neurodegenerative diseases are a group of progressive disorders that  affect the central nervous system (CNS) such as Alzheimer, Parkinson, and multiple sclerosis. Inflammation plays a critical role in the onset and progression of these injuries. Periodontitis is considered [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hojjatollah Farahani
Oral Presentation (Virtual)
Hojjatollah Farahani, Tarbiat Modares University, Iran (Islamic Republic of)

Research is core of science and improving methodology leads to realistic findings.  Assessing the impact of main factors on a given factor is important in various fields of psychological research. There are some methodological and statistical methods to tackle that problem. [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Nishi M Satish
Oral Presentation (Virtual)
Nishi M Satish, VMMC and Safdarjung Hospital, India

Lebers hereditary optic neuropathy (LHON) is a mitochondrial genetic disease that preferentially causes blindness in young males, prevalence between 1 in 8500 and 1 in 50000. It is an inherited neuropathy characterized by bilateral subacute loss of central vision owing to focal d [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mohammad Abu-Abaa
Oral Presentation (Virtual)
Mohammad Abu-Abaa, Capital Health Internal Medicine Residency, United States

This is a case report of a 45 years old female patient with a past medical history of depression and poor oral intake presented for a single episode of unwitnessed seizure and 3 days of unsteady gait and vertigo. Then she had two episodes of seizure focal and then generalized ton [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Manuel Narváez Peláez
Oral Presentation (Virtual)
Manuel Narváez Peláez, University of Malaga, Spain

Accumulating evidence for Neuropeptide Y (NPY) and galanin (GAL) interaction was shown in various limbic system regions at molecular-, cellular- and behavioral-specific levels. Dysregulation of hippocampal neurogenesis is linked to several neurodegenereative diseases and depressi [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hamza Islam
Oral Presentation (Virtual)
Hamza Islam, Punjab Medical College, Pakistan

Mitral stenosis (MS), a valvular heart disease, is defined by the narrowing of the mitral valve orifice. The common risk factors for stroke include mitral annular calcification (MAC), diabetes mellitus (DM), male gender, hypertension (HTN), hyperlipidemia, and obesity. Endothelia [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Paul Raj
Oral Presentation (Virtual)
Paul Raj, Jyoti Nivas College, India

Reading is an important skill for mastery in social relationships, academic performance, emotional regulation and most types of work. Reading impairments, one of the most common neurodevelopmental disorders affecting approximately 5-10% of school-going children across languages, [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Maria Joao Sacadura
Oral Presentation (Virtual)
Maria Joao Sacadura, Catholic University of Portugal and University of Coimbra, Portugal

The present communication proposes are question how the family and the community are structuring actors in the management of chronic kidney disease; questions the habits and routines of a chronic renal patient based on the neurosciences approach and relates this information to co [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Esraa Askar
Oral Presentation (Virtual)
Esraa Askar, Northwell/Hofstra Zucker School of Medicine, United States

Introduction: Early aortic graft infections, which can arise within 4 months of endovascular graft repair, frequently present as high-grade infections. However, late infections can be challenging to detect due to nonspecific symptoms. This case report discusses a late aortic graf [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Joseph bose
Oral Presentation (Virtual)
Joseph bose, National Institute of Speech and Hearing (NISH), India

Eating is the most basic ADL (Activities for Daily Living) necessary for survival from birth until death. Dysphagia is a swallowing disorder that can occur in any stage of swallowing. Occupational therapists are trained to assess and provide intervention in the process of eating. [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Cristian Ravariu
Oral Presentation (Virtual)
Cristian Ravariu, Polytechnic University of Bucharest, Romania

To make possible a systemic methodology for the treatment of the neuromuscular pathology, some models must be developed to predict what stimulus can optimal interfere with the system function in order to modify its state. Stripped muscles are part of somatic system - the interact [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Muhesh Taheem
Oral Presentation (Virtual)
Muhesh Taheem, Imperial College London, United Kingdom

The increasing prevalence of blast traumatic brain injury (bTBI) in military personnel has stimulated further research into this field. The neuroendocrine system can be severely affected in blast survivors and anterior pituitary dysfunction has been characterised in soldiers retu [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Matineh Nirouei
Oral Presentation (Virtual)
Matineh Nirouei, Alborz University of Medical Sciences, Iran (Islamic Republic of)

Giant cell arteritis (GCA) is a common and inflammatory condition that almost exclusively affect adults older than 50 years. GCA is a systemic vasculitis that involves medium-sized and larger arteries. GCA rarely can affect the brain-arteries, resulting in ischemic strokes a [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Georgios Matis
Oral Presentation (Virtual)
Georgios Matis, University Cologne Hospital, Germany

Ziconotide is a synthetic, water-soluble cone snail venom-derived peptide with a molecular weight of 2,639 Daltons. It is a nonopioid analgesic that selectively binds to N-type voltage-sensitive calcium channels on primary nociceptive afferent nerves in the dorsal horn of the spi [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Julia Guimaraes
Poster Presentation (Virtual)
Julia Guimaraes, UOC, Romania

The novel Coronavirus (COVID-19) was first reported by officials in Wuhan City, in December of 2019. It has rapidly widespread with confirmed cases in almost every country across the world and has become a new global public health crisis.1 Weekly epidemiological update of the Wor [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Agouni Chaima
Poster Presentation (Virtual)
Agouni Chaima, CHU Constantine, Algeria

Introduction : PHARC is an acronym that describes the major features of an early onset neurodegenerative disease marked by Cataract, Hearing loss, Retinitis pigmentosa and involvement of central and peripheral nervous systems, including sensorimotor PolyNeuropathy and cer [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Marcia Castillo
Poster Presentation (Virtual)
Marcia Castillo, Centro de Salud Fundación Activo 20-30, Dominican Republic

Background: Parkinson’s disease (PD) is usually more prevalent in men than in women, which has been explained in terms of environmental, hormonal and genetic influences, but little has been reported in terms of clinical characteristics among sex. Objective: to analyze mo [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Vanessa Veronica
Poster Presentation (Virtual)
Vanessa Veronica, Duta Wacana Christian University, Indonesia

Background. It has long been recognized that inflammation plays a critical role in the pathogenesis of ischemic stroke. However, whether leukocyte count and neutrophil-to-lymphocyte ratio are related to stroke severity and functional outcome is uncertain. Objective. This clini [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Jaidi Sagay
Poster Presentation (Virtual)
Jaidi Sagay, BGHMC, Philippines

INTRODUCTION: Autoimmune Encephalitis is a debilitating neurological disorder that develops as a rapidly progressive encephalopathy, occurring usually less than 6 weeks, caused by brain inflammation. There are limited data on the autoimmune cases in the locality. This study aims [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Khadga Raj Aran
Poster Presentation (Virtual)
Khadga Raj Aran, ISF College of Pharmacy, India

Introduction Parkinson’s disease (PD) is a chronic neurodegenerative disorder triggered by degeneration of dopaminergic neurons in substantia nigra pars compacta (SNpc). Low antioxidant level, mitochondrial failure and neuroinflammation are the major pathological mechani [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mouna
Poster Presentation (Virtual)
Mouna, Fattouma Bourguiba University Hospital, Tunisia

Background : Patent Foramen Ovale (PFO) has been associated with Embolic Stroke of Undetermined Source (ESUS). It remains uncertain whether PFO is the direct etiology or an incidental finding. The aim of our study was to analyze the incidence and characteristics of PFO in [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Camelia Porey
Poster Presentation (Virtual)
Camelia Porey, AIIMS, India

Background: Antiphospholipid antibody (APLA) syndrome is an autoimmune disorder predisposing to thrombotic complications affecting CNS either by arterial vasooclusion or venous thrombosis. Cerebral venous sinus thrombosis (CVST) secondarily cause raised intracranial pressure ( [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Brianna Scott
Poster Presentation (Virtual)
Brianna Scott, LSUS/LSU Health Sciences Center - Shreveport, United States

Throughout the years epidemiological studies have been used to assess the burden of neurological disorders and disease conditions. Although many advancements have been made in the field, not enough data is available on intervention and reduction of the comorbid conditions of neur [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - David Galel
Poster Presentation (Virtual)
David Galel, Rosalind Franklin University of Medicine and Science, United States

Multiple Sclerosis (MS) is an autoimmune disease targeting myelin in the central nervous system. Most disease modifying therapies (DMTs) for MS function via immunomodulation by a variety of modalities, some of which are immunosuppressive and some which are not. In this study we c [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Hannah Girgis
Poster Presentation (Virtual)
Hannah Girgis, Aultman Hospital, United States

Neurofibromatosis type 2 (NF2) is a genetic disorder that predisposes individuals to multiple tumors of the nervous system. The most common of these are bilateral vestibular schwannomas; intracranial and spinal meningiomas, and spinal cord ependymomas. The condition is caused by [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Claudia Jessy Henriquez
Poster Presentation (Virtual)
Claudia Jessy Henriquez, Baylor College of Medicine, United States

Elevated intracranial pressure (ICP) has been described in patients with demyelinating diseases of the central nervous system (CNS). Elevated ICP is classified into idiopathic intracranial hypertension (IIH), where a clear precipitant is not found; and secondary intracranial hype [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Yusupova Dilnoza
Poster Presentation (Virtual)
Yusupova Dilnoza, Tashkent Medical Academy, Uzbekistan

Background and aims To clarify the role of the al-subunit of the neuronal sodium channel (SCN1A) gene in the development of catamenial epilepsy in the patients we examined, the study analyzed the associations of polymorphic DNA loci D2S2330 and D2S124 linked to the SCN1A gene and [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Priyanka Puri
Poster Presentation (Virtual)
Priyanka Puri, Punjab university, India

Parkinson 's d isease is a second most commo n age-related neurodegenerative d isorder characterized by tbe loss of dopaminergic nemons in the substantia nigra pars compacta region of the midbrain. Doxophylline is a non-selective PDE inhibitor and thus expected to be benefici [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Siri Tummala
Poster Presentation (Virtual)
Siri Tummala, TCU School of Medicine, United States

Spinal surgery is the final option recommended to individuals with spinal conditions when conservative treatment has failed in treating patients’ symptoms. The purpose of this study is to examine the factors contributing to patients’ readiness to undergo recommended s [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Wing Kiu Chou
Poster Presentation (Virtual)
Wing Kiu Chou, University of East Anglia, United Kingdom

Multiple sclerosis (MS)  is a chronic, degenerative inflammatory disease of the central nervous system characterised by demyelination. Genetic factors have been implicated in its pathogenesis, however their association with MS remains unclear. Genetic variants in the  i [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Xiaoyi Gao
Poster Presentation (Virtual)
Xiaoyi Gao, St. Louis University School of Medicine, United States

The SLU AMSAD is a previously validated depression tool that consists of 5-items and takes less than 2 minutes to administer. The Cornell Scale for Depression in Dementia (CSDD) is the gold standard for assessing depression in dementia patients, but is lengthy, taking nearly 20 m [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Shreenal Patel
Poster Presentation (Virtual)
Shreenal Patel, HCA healthcare Houston, United States

Introduction: Neurosarcoidosis is an uncommon manifestation and should be suspected in any patients with sarcoidosis with new neurological symptoms. We present a rare case of probable neurosarcoidosis, which was diagnosed by exclusion and elevated acetylcholinesterase (ACE) le [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Anthia Papazoglou
Poster Presentation (Virtual)
Anthia Papazoglou, Cantonal Hospital Aarau, Switzerland

Background. Optic neuritis and optic neuropathy can cause a reduced color-sensitivity. Therefore, in clinical routine the patient's perception of the red color is tested in order to evaluate the function of the optic nerve. Red desaturation is traditionally tested by presenti [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Giancarlo Denaroso
Poster Presentation (Virtual)
Giancarlo Denaroso, University at Buffalo, United States

Multiple sclerosis (MS), an autoimmune disorder of the central nervous system (CNS), is characterized by inflammatory cell infiltration and myelin destruction. In addition to systemic activation of peripheral immune cells, the activation and proliferation of astrocytes and microg [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Zhi-Hao Liu
Poster Presentation (Virtual)
Zhi-Hao Liu, Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, China

Short Description of what will be discussed during the presentation (about 250 - 500 words)

Speaker at Neurology and Brain Disorders 2022 - Abdul Wahab
Poster Presentation (Virtual)
Abdul Wahab, Department of Microbiology, Pakistan

Malaria elimination strategies demand constant monitoring of the parasite population for genetic variations that necessitate a public health response, such as a new form of drug resistance. Malaria control relies mainly on rapid and precise diagnosis, followed by successful treat [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - John Carbone
Poster Presentation (Virtual)
John Carbone, Metro South Health, Australia

Background: Intracranial arachnoid cysts are collections of cerebrospinal fluid that are likely benign and asymptomatic. A subset of patients go on to have neurosurgical intervention. The imaging and clinical presentation findings should guide surgical decision making in a st [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mohammad Abu-Abaa
Poster Presentation (Virtual)
Mohammad Abu-Abaa, Capital Health Internal Medicine Residency, United States

A 43 years old male patient with a past medical history of hypertension and hyperlipidemia but noncompliant with medications presented to the hospital after his coworkers noticed a left sided facial droop. He also reports a transient episode of dizziness in the same morning. In E [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Joshua Burshtein
Poster Presentation (Virtual)
Joshua Burshtein, Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, United States

Background & Purpose Knowledge surrounding inpatient costs of bacterial meningitis (BM) management is limited. We aimed to explore the financial burden of hospitalization due to BM, including cost trends over time and factors associated with higher costs. Methods We [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Julia Augusta Guimarães Dourado
Poster Presentation (Virtual)
Julia Augusta Guimarães Dourado, Universitatea “Ovidius” din Constanța, Romania

Background:The novel Coronavirus (COVID-19) was first reported by officials in Wuhan City, in December of 2019. It has rapidly widespread with confirmed cases in almost every country across the world and has become a new global public health crisis.1 Weekly epidemiological update [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Ryane Elizabeth Adams
Poster Presentation (Virtual)
Ryane Elizabeth Adams, McGovern Medical School, United States

Introduction: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is defined as an autoimmune disease of the CNS associated with a serological antibody against myelin oligodendrocyte glycoprotein (MOG). MOG is found within the CNS: the optic nerves, brain, and spinal co [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Gabriela Dumitrita Stanciu
Poster Presentation (Virtual)
Gabriela Dumitrita Stanciu, Grigore T. Popa” University of Medicine and Pharmacy, Romania

As one of the major healthcare challenges worldwide, Alzheimer’s disease (AD) is a detrimental brain disorder of a multifactorial nature, with an etiopathogenesis still not completely clear, influenced by epigenetic and genetic variants combined with environmental and lifes [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - T Karthikeyan
Poster Presentation (Virtual)
T Karthikeyan, NIMHANS, India

Background: Stroke is characterized by acute onset of neurological dysfunction due to abnormality in cerebral circulation with resultant signs and symptoms that correspond to involvement of the focal areas of brain. Aim: The aim of the study to identify the conventional physioth [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Bryan Leonard M Quizon
Poster Presentation (Virtual)
Bryan Leonard M Quizon, National Kidney and Transplant Institute, Philippines

Lance-Adams Syndrome (LAS) or chronic Post-Hypoxic Myoclonus (PHM) was first described in 1963 by Lance and Adams, in patients presenting with action myoclonus after hypoxic brain injury from cardiac arrest. Since then, only fewer than 150 cases have been reported in registries w [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Esraa Askar
Poster Presentation (Virtual)
Esraa Askar, Northwell/Hofstra Zucker School of Medicine, United States

Introduction: Transient global amnesia (TGA) involves a sudden onset of anterograde and retrograde amnesia, often accompanied by executive dysfunction, typically lasting up to 24 hours, and not linked to another neurological impairment. Case Presentation: A 52-year-o [....] » Read More

Speaker at Neurology and Brain Disorders 2022 -  Patrick Brown
Poster Presentation (Virtual)
Patrick Brown, The University of Queensland, United States

Objective: The purpose of this study was to evaluate the development of clinically diagnosed anxiety or depression within one year following a minor traumatic brain injury (mTBI). Design: A state-wide hospital system (Ochsner Health) retrospective cohort analysis  Settin [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Mohammad Abu-Abaa
Poster Presentation (Virtual)
Mohammad Abu-Abaa, Capital Health Internal Medicine Residency, United States

A 56 years old female patient presented with a few weeks of persistent nausea, vomiting, watery diarrhea, generalized itching and unintentional weight loss. She denied alcohol intake. Labs showed mild hypercalcemia at 10.6 mg/dl. Abdominal examination was benign. Investigations [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Kayleigh Jessop
Poster Presentation (Virtual)
Kayleigh Jessop, East Kent Hospitals University NHS Foundation Trust, United Kingdom

A woman in her 90s with a background of myasthenia gravis and atrial fibrillation presented to hospital following a fall. Whilst in ED it was noted that she was in atrial fibrillation with a fast-ventricular response and as part of her management was given intravenous (IV) magnes [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Meyrav Gaziel Guttman
Poster Presentation (Virtual)
Meyrav Gaziel Guttman, Bar-Ilan university, Israel

The associations between social anxiety (SA) and impaired responses to interpersonal touch for adults with autism spectrum disorder (ASD) were explored before. However, the neural correlates of SA levels and interpersonal touch among this group in comparison with a typical group [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Pei-Chuan Wu
Poster Presentation (Virtual)
Pei-Chuan Wu, Far Eastern Memorial Hospital, Taiwan

Sialorrea as a side effect is commonly reported when treating patients with antipsychotic drugs, notably clozapine. The proposed mechanism of antipsychotic induced sialorrhea includes the contribution to hypersecretion of saliva and the dysfunction of removing saliva from the mou [....] » Read More

Speaker at Neurology and Brain Disorders 2022 - Pourya Bahiraei
Poster Presentation (Virtual)
Pourya Bahiraei, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Background: Behcet's syndrome (BS) is an idiopathic vasculitis disease, which causes a wide spectrum of different focal and systemic symptoms. This review aimed to investigate the neuropsychiatric and cognitive aspects of this syndrome. Method: Using the keywords "psy [....] » Read More

Watsapp